GERMINAL CENTER CELLS EXPRESS BCL-2 PROTEIN AFTER ACTIVATION BY SIGNALS WHICH PREVENT THEIR ENTRY INTO APOPTOSIS

被引:436
作者
LIU, YJ
MASON, DY
JOHNSON, GD
ABBOT, S
GREGORY, CD
HARDIE, DL
GORDON, J
MACLENNAN, ICM
机构
[1] UNIV BIRMINGHAM, SCH MED, DEPT IMMUNOL, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND
[2] JOHN RADCLIFFE HOSP, DEPT HAEMATOL, OXFORD OX3 9DU, ENGLAND
关键词
D O I
10.1002/eji.1830210819
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cells undergo selection within germinal centers on the basis of their capacity to be activated by antigen held on follicular dendritic cells. Isolated germinal center B cells in culture kill themselves by apoptosis but this is prevented if their receptors for antigen are cross-linked. In this study it is confirmed that almost all germinal center B cells, unlike other B cells, do not express the 25-kDa protein encoded by the bcl-2 oncogene. Cross-linking the surface Ig of isolated germinal center cells causes them to express bcl- protein. Two other stimuli which inhibit the entry of germinal center cells to apoptosis result in the expression of bcl-2 protein. These stimuli are: (a) CD40 antibody and (b) recombinant 25-kDa fragment of the CD23 protein plus recombinant interleukin 1-alpha. Respectively, these induce germinal center cells to differentiate to resting B cells or plasmablasts. Dual-fluorescence studies on small lymphocytes confirm the presence of bcl-2 protein in mitochondria but show that this is also present in other extra-nuclear areas. Burkitt lymphoma cells have a phenotype which indicates that they are neoplastic cells of germinal center origin. The expression of bcl-2 protein by Burkitt lymphoma lines was also studied. Burkitt lines which retain the phenotype of fresh Burkitt lymphoma cells can be induced to enter apoptosis on culture with the Ca2+ ionophore ionomycin. These cells were found not to express bcl-2 protein. By contrast, Burkitt lines which have drifted towards a lymphoblastoid cell line phenotype and are resistant to the induction of apoptosis express high levels of the bcl-2 protein. The findings support the concept that the susceptibility of germinal center cells to entering apoptosis is associated with their lack of expression of bcl-2 protein. Aberrant expression of bcl-2 protein by some neoplastic germinal center cells may allow survival in situations where their normal counterparts die.
引用
收藏
页码:1905 / 1910
页数:6
相关论文
共 36 条
  • [1] MOLECULAR EVENTS DURING MATURATION OF THE IMMUNE-RESPONSE TO OXAZOLONE
    BEREK, C
    GRIFFITHS, GM
    MILSTEIN, C
    [J]. NATURE, 1985, 316 (6027) : 412 - 418
  • [2] HEAVY-CHAIN VARIABLE REGION CONTRIBUTION TO THE NPB FAMILY OF ANTIBODIES - SOMATIC MUTATION EVIDENT IN A GAMMA-2A VARIABLE REGION
    BOTHWELL, ALM
    PASKIND, M
    RETH, M
    IMANISHIKARI, T
    RAJEWSKY, K
    BALTIMORE, D
    [J]. CELL, 1981, 24 (03) : 625 - 637
  • [3] CHAN EYT, 1991, THESIS U BIRMINGHAM
  • [4] THE BCL-2 CANDIDATE PROTO-ONCOGENE PRODUCT IS A 24-KILODALTON INTEGRAL-MEMBRANE PROTEIN HIGHLY EXPRESSED IN LYMPHOID-CELL LINES AND LYMPHOMAS CARRYING THE T(14,18) TRANSLOCATION
    CHENLEVY, Z
    NOURSE, J
    CLEARY, ML
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (02) : 701 - 710
  • [5] COICO RF, 1983, J IMMUNOL, V131, P2254
  • [6] CELL PROLIFERATION IN GERMINAL CENTERS OF RAT SPLEEN
    FLIEDNER, TM
    ROBERTSON, JS
    CRONKITE, EP
    KESSE, M
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1964, 113 (A2) : 578 - &
  • [7] GALTON DAG, 1982, CLIN HAEMATOL, V11, P561
  • [8] DIFFERENT EPSTEIN-BARR VIRUS-B CELL-INTERACTIONS IN PHENOTYPICALLY DISTINCT CLONES OF A BURKITTS-LYMPHOMA CELL-LINE
    GREGORY, CD
    ROWE, M
    RICKINSON, AB
    [J]. JOURNAL OF GENERAL VIROLOGY, 1990, 71 : 1481 - 1495
  • [9] DOWN-REGULATION OF CELL-ADHESION MOLECULES LFA-3 AND ICAM-1 IN EPSTEIN-BARR VIRUS-POSITIVE BURKITTS-LYMPHOMA UNDERLIES TUMOR-CELL ESCAPE FROM VIRUS-SPECIFIC T-CELL SURVEILLANCE
    GREGORY, CD
    MURRAY, RJ
    EDWARDS, CF
    RICKINSON, AB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) : 1811 - 1824
  • [10] GREGORY CD, 1987, J IMMUNOL, V139, P313